Assign significance rank to pharmaceutical
Showing 1 - 25 of 4,028
End Stage Renal Disease Trial (Behavioral Patient care)
Withdrawn
- End Stage Renal Disease
- Behavioral Patient care
- (no location specified)
Jul 17, 2023
Acupuncture, Depression Trial (cheek acupuncture)
Not yet recruiting
- Acupuncture
- Depression
- cheek acupuncture
- (no location specified)
Jun 19, 2023
Hypertension Trial (Pharmaceutical care via telepharmacy and usual care, Pharmaceutical care in-person and usual care)
Not yet recruiting
- Hypertension
- Pharmaceutical care via telepharmacy and usual care
- Pharmaceutical care in-person and usual care
- (no location specified)
Nov 1, 2023
Patient Preferences With Pharmaceutical Care: In-person Versus
Recruiting
- Patient Preference
- Survey
-
Beirut, Mount Lebanon, Lebanon
- +1 more
Aug 11, 2023
Allergic Rhinitis, Pharmaceutical Care, Pharmaceutical Services Trial in Ipoh (pharmacist-led education)
Recruiting
- Allergic Rhinitis
- +2 more
- pharmacist-led education
-
Ipoh, Perak, MalaysiaRaja Permaisuri Bainun Hospital
Aug 30, 2023
Anticoagulants, Intention, Behavioral Symptoms Trial in Beijing (Pharmacists' intervention)
Recruiting
- Anticoagulants
- +2 more
- Pharmacists' intervention
-
Beijing, Beijing, China
- +1 more
Oct 9, 2022
A Single Dry EEG Electrode Allows to Estimate of Level of
Completed
- Anesthesia; Adverse Effect
- volunteer anesthesiologists and nurses
-
Volterra, Pisa, ItalySanta Maria Maddalena Hospital
Jan 20, 2023
Social Anxiety Disorder Trial in Hartford (Fear extinction, Cannabidiol Cap/Tab, Placebo)
Not yet recruiting
- Social Anxiety Disorder
- Fear extinction
- +2 more
-
Hartford, ConnecticutAnxiety Disorders Center, Institute of Living
Nov 7, 2023
Gastric Cancer, NSCLC, Colo-rectal Cancer Trial in Changchun (Ramucirumab Injection, Ramucirumab Injection [Cyramza])
Completed
- Gastric Cancer
- +2 more
- Ramucirumab Injection
- Ramucirumab Injection [Cyramza]
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Mar 24, 2023
Stroke Trial in Istanbul (Clinical Pharmacist Led Pharmaceutical Care)
Completed
- Stroke
- Clinical Pharmacist Led Pharmaceutical Care
-
Istanbul, TurkeyMarmara University Pendik Research and Training Hospital
Nov 8, 2023
Laparoscopy, Anesthesia, Intravenous Trial in China (BT-KTM-I, Ketanest®S)
Not yet recruiting
- Laparoscopy
- Anesthesia, Intravenous
-
Guangzhou, Guangdong, China
- +11 more
Oct 15, 2023
Healthy Trial in Cairo (Bravamax 200 mg (Modafinil), Vigil 200 mg (Modafinil))
Completed
- Healthy
- Bravamax 200 mg (Modafinil)
- Vigil 200 mg (Modafinil)
-
Cairo, EgyptGenuine Research Center GRC
May 3, 2023
Healthy Subjects Trial in Shanghai (Part A ABSK201 and Itraconazole, Part A ABSK201 and Rifampicin)
Enrolling by invitation
- Healthy Subjects
- Part A ABSK201 and Itraconazole
- Part A ABSK201 and Rifampicin
-
Shanghai, Shanghai, ChinaHuashan Hospital Fudan University
Oct 12, 2023
Ankylosing Spondylitis Trial in Karabuk (wet cupping therapy)
Enrolling by invitation
- Ankylosing Spondylitis
- wet cupping therapy
-
Karabuk, TurkeyKarabuk University
Mar 18, 2023
Malocclusion, Pain, Acute Trial in Guadalajara (Ketorolac)
Recruiting
- Malocclusion
- Pain, Acute
-
Guadalajara, Jaisco, MexicoJuan Ramón Gómez Sandoval
May 16, 2022
rTEM in the Prognosis and Severity of Sepsis Induced ARDS
Not yet recruiting
- Sepsis
- Taking peripheral blood
- (no location specified)
Oct 1, 2023
Epicardial Fat Thickness in Children With Familial Dyslipidemia
Not yet recruiting
- Dyslipidemia
- echoCARDIOGRAPHY
- (no location specified)
Oct 22, 2023
AIS and START Grade With Films Transferring in Disaster
Not yet recruiting
- Trauma
- Disaster
- AIS,START with films transferring
- (no location specified)
Oct 7, 2022
Submaximal CPET in Treatment Management of PAH
Not yet recruiting
- Pulmonary Arterial Hypertension
- Shape II CPET
-
Torrance, California
- +5 more
Aug 4, 2023
Retrospective Review of Esophageal Cancer at MSKCC
Recruiting
- Esophageal Cancer
- Esophagus Cancer
- Esophagectomy
-
New York, New YorkMemorial Sloan Kettering Cancer Center (All Protocol Activities)
Jan 23, 2023
Alcohol Use Disorder Trial in Aurora (Semaglutide 3 MG [Rybelsus], Semaglutide 7 MG [Rybelsus], Placebo)
Not yet recruiting
- Alcohol Use Disorder
- Semaglutide 3 MG [Rybelsus]
- +2 more
-
Aurora, ColoradoUniversity of Colorado Anschutz Medical Campus
Jun 6, 2023
Real World, Pharmacy-assessed Adherence to New Onset Entresto®
Not yet recruiting
- Heart Failure
- sacubitril/valsartan
- (no location specified)
May 12, 2023
Personalized Pharmaceutical Plan After Transpantation Trial in France (PPP)
Active, not recruiting
- Personalized Pharmaceutical Plan After Transpantation
- PPP
-
Brest, France
- +11 more
Nov 2, 2022
Locally Advanced or Metastatic Solid Tumors Trial in Shanghai (Anti-5T4 CAR-raNK Cells)
Recruiting
- Locally Advanced or Metastatic Solid Tumors
- Anti-5T4 CAR-raNK Cells
-
Shanghai, Shanghai, ChinaShanghai East Hospital
Oct 25, 2022
Gastrointestinal Stromal Tumors, Renal Cell Carcinoma, Pancreatic Neuroendocrine Tumor Trial in Changchun (Sunitinib malate
Completed
- Gastrointestinal Stromal Tumors
- +2 more
- Sunitinib malate capsules generic product
- Sunitinib malate capsules reference product
-
Changchun, Jilin, ChinaAffiliated Hospital of Changchun University of Traditional Chine
Apr 6, 2023